Selegiline

DRUG14 trials

Sponsors

University of Pennsylvania, National Institute on Drug Abuse (NIDA), Yale University, Tabriz University, Stanford University

Conditions

Adenocarcinoma of the ProstateAmphetamine-Related DisordersBorderline Personality DisorderCocaine Use DisordersCocaine-Related DisordersErectile DysfunctionMetastatic Castration-resistant Prostate CancerParkinson Disease

Early Phase 1

Efficacy of Selegiline in Negative Symptoms of Schizophrenia

CompletedNCT00456976

Tabriz UniversitySchizophrenia

Start: 2007-04-30End: 2007-09-30Target: 70Updated: 2008-07-23

Phase 1

Infusion Laboratory: Protocol 1 - Selegeline - 2

CompletedNCT00000337

National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders

Start: 1994-11-30Updated: 2017-01-12

Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

National Institute on Drug Abuse (NIDA)Amphetamine-Related Disorders

Start: 2001-09-30End: 2002-10-31Target: 16Updated: 2017-01-11

Phase 2

Selegiline in Treatment of Cocaine Dependence - 2

CompletedNCT00000188

University of PennsylvaniaCocaine-Related Disorders

Start: 1994-09-30End: 1995-10-31Updated: 2015-05-28

Pharmacological Modulation of Cocaine Effects - 1

CompletedNCT00000201

National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders

End: 2001-12-31Updated: 2017-01-12

Selegiline in Outpatient Treatment for Cocaine Dependence - 1

CompletedNCT00000336

National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders

Start: 1995-01-31End: 1996-03-31Updated: 2017-01-16

Usefulness of Selegiline as an Aid to Quit Smoking - 1

CompletedNCT00129311

Yale UniversityTobacco Use Cessation

Start: 2004-07-31End: 2012-12-31Updated: 2015-03-31

Selegiline Patch for Treatment of Nicotine Dependence

CompletedNCT01330030

Stanford UniversityTobacco Use Disorder

Start: 2005-07-31End: 2011-07-31Updated: 2016-08-10

Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior

CompletedNCT01495195

Midwest Biomedical Research FoundationCocaine Use Disorders

Start: 2012-02-29End: 2013-05-31Updated: 2013-12-18

Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma

László MangelAdenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer

Start: 2020-05-18End: 2025-02-01Target: 110Updated: 2020-10-14

Phase 3

Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1

CompletedNCT00032929

National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders

Start: 2001-03-31Updated: 2017-01-12

Clinical Research Study to Evaluate Selegiline in the Treatment of Borderline Personality Disorder

CompletedNCT01912391

Mood and Anxiety Research, IncBorderline Personality Disorder

Start: 2012-10-31End: 2015-03-31Updated: 2015-10-08

Phase 4

Sagene 2014 - Parkinson's Disease and Erectile Dysfunction

University of South FloridaErectile Dysfunction, Parkinson's Disease

Start: 2014-09-30End: 2019-01-31Target: 10Updated: 2017-12-20

Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease

CompletedNCT04870372

Second Affiliated Hospital of Soochow UniversityParkinson Disease

Start: 2020-03-01End: 2021-04-30Updated: 2021-05-07

Related Papers

Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study

Chinese Medical Journal2022-07-205 citations